Health ❯ Healthcare ❯ Oncology

Drug Development

Targeted Therapies Clinical Trials Antibody-Drug Conjugates New Agents FDA Approval MYC Proteins Radiopharmaceuticals RAS Proteins Clinical Research Oncology Center of Excellence BNT327 Repurposing Medications Black Diamond Therapeutics

Gilead to Acquire Tubulis for Up to $5 Billion to Boost Cancer ADC Pipeline

Closing expected in Q2 2026 would put Tubulis’ Munich site at the center of Gilead’s ADC research.

Silevertinib Delivers 60% Response and Strong CNS Activity in First-Line NSCLC With Non-Classical EGFR Mutations

Kriya Nets $320 Million Series D as Odyssey Raises $213 Million and Amgen Retools Research Leadership